Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sulfosuccinimidyl 4-(n-maleimidomethyl)cyclohexane-1-carboxylate
1. 92921-24-9
2. Sulfo-smcc Sodium
3. Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
4. Sulfo-smcc (sodium)
5. Sulfo-smcc Crosslinker
6. Hh32d7tn36
7. 92921-24-9 (sodium)
8. Sodium 1-((4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexane-1-carbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
9. Sulfo-n-succinimidyl 4-(maleimidomethyl)cyclohexane-1-carboxylate Sodium Salt
10. 4-(maleimidomethyl)cyclohexane-1-carboxylic Acid 3-sulfo-n-hydroxysuccinimide Ester Sodium Salt
11. 3-pyrrolidinesulfonic Acid, 1-(((4-((2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)methyl)cyclohexyl)carbonyl)oxy)-2,5-dioxo-, Sodium Salt
12. Cyclohexanecarboxylic Acid, 4-((2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)methyl)-, 2,5-dioxo-3-sulfo-1-pyrrolidinyl Ester, Sodium Salt (1:1)
13. Sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate
14. Sulfo-smcc Sodium Salt
15. Unii-hh32d7tn36
16. Schembl18344257
17. Dtxsid80404961
18. Hy-d0975
19. Mfcd00054978
20. Akos022186734
21. Sulphosuccinimidyl-4-(n-maleimidomethyl)cyclohexane-1-carboxylate Sodium Salt
22. Cs-7553
23. Sb19635
24. Ac-33930
25. As-11382
26. Bp-22644
27. Bp-24304
28. Ft-0674774
29. S0883
30. H10470
31. 3-sulfo-n-succinimidyl 4-(n-maleimidomethyl)cyclohexane-1-carboxylate Sodium Salt
32. Sulfo-n-succinimidyl 4-(maleimidomethyl)cyclohexane-1-carboxylate, Sodium Salt, 90%
33. Sulfo-n-succinimidyl 4-(maleimidomethyl)cyclohexane-1-carboxylate, Sodium Salt, 90per Cent
34. 4-(2,5-dioxo-1h-pyrrole-1-ylmethyl)cyclohexanecarboxylic Acid 3-(sodiosulfo)-2,5-dioxopyrrolizino
35. 4-(n-maleimidomethyl)cyclohexane-1-carboxylic Acid 3-sulfo-n-hydroxysuccinimide Ester Sodium Salt, Powder
36. 4beta-[(2,5-dioxo-2,5-dihydro-1h-pyrrole-1-yl)methyl]cyclohexane-1alpha-carboxylic Acid 3-(sodiosulfo)succinimidyl Ester
37. Sodium 1-{4-[(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl]cyclohexanecarbonyloxy}-2,5-dioxopyrrolidine-3-sulfonate
38. Sodium1-((4-((2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)methyl)cyclohexanecarbonyl)oxy)-2,5-dioxopyrrolidine-3-sulfonate
| Molecular Weight | 436.4 g/mol |
|---|---|
| Molecular Formula | C16H17N2NaO9S |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 436.05524558 g/mol |
| Monoisotopic Mass | 436.05524558 g/mol |
| Topological Polar Surface Area | 167 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 853 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Sulfo-Smcc manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sulfo-Smcc, including repackagers and relabelers. The FDA regulates Sulfo-Smcc manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sulfo-Smcc API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sulfo-Smcc supplier is an individual or a company that provides Sulfo-Smcc active pharmaceutical ingredient (API) or Sulfo-Smcc finished formulations upon request. The Sulfo-Smcc suppliers may include Sulfo-Smcc API manufacturers, exporters, distributors and traders.
click here to find a list of Sulfo-Smcc suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sulfo-Smcc DMF (Drug Master File) is a document detailing the whole manufacturing process of Sulfo-Smcc active pharmaceutical ingredient (API) in detail. Different forms of Sulfo-Smcc DMFs exist exist since differing nations have different regulations, such as Sulfo-Smcc USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sulfo-Smcc DMF submitted to regulatory agencies in the US is known as a USDMF. Sulfo-Smcc USDMF includes data on Sulfo-Smcc's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sulfo-Smcc USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sulfo-Smcc suppliers with USDMF on PharmaCompass.
Sulfo-Smcc Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sulfo-Smcc GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sulfo-Smcc GMP manufacturer or Sulfo-Smcc GMP API supplier for your needs.
A Sulfo-Smcc CoA (Certificate of Analysis) is a formal document that attests to Sulfo-Smcc's compliance with Sulfo-Smcc specifications and serves as a tool for batch-level quality control.
Sulfo-Smcc CoA mostly includes findings from lab analyses of a specific batch. For each Sulfo-Smcc CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sulfo-Smcc may be tested according to a variety of international standards, such as European Pharmacopoeia (Sulfo-Smcc EP), Sulfo-Smcc JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sulfo-Smcc USP).
LOOKING FOR A SUPPLIER?
